瘤组织中的氧度梯度对乳腺癌转移的影响 - - 叙述性综述
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Annals of medicine and surgery (2012)
|June 9, 2025
概括
瘤缺氧或低氧,通过激活缺氧诱导因子 (HIFs) 来促进乳腺癌转移. 这些因素促进癌细胞迁移,入侵和免疫逃避,推动疾病的进展.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 瘤微环境研究 研究
背景情况:
- 瘤内的氧气梯度是乳腺癌进展和转移的关键驱动因素.
- 瘤缺氧是由快速生长和不充分的血管化引起的,引发了适应性反应.
- 缺氧诱导因子 (HIFs) 是基因参与转移的关键调节者.
研究的目的:
- 阐明氧度梯度在乳腺癌转移中的作用.
- 了解缺氧如何影响瘤微环境和免疫逃避.
- 探索缺氧促进癌细胞扩散的机制.
主要方法:
- 通过低氧诱导因素 (HIFs) 调节的基因表达的分析.
- 细胞过程的研究,包括血管新生和上皮细胞转化为介质细胞转化 (EMT).
- 在低氧瘤区域内评估免疫细胞透和功能.
主要成果:
- 缺氧激活HIFs,这些HIFs促进血管生成,EMT和免疫逃避.
- 低毒瘤微环境通过招募调节性免疫细胞来促进免疫抑制.
- 缺氧诱导的血管生成促进癌细胞进入循环,以进行远程播种.
结论:
- 氧度梯度和瘤缺氧是导致乳腺癌转移的重要因素.
- 瘤微环境的低氧驱动的变化促进了免疫逃避和癌细胞的传播.
- 向与缺氧相关的途径是抑制乳腺癌转移的潜在策略.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...


